SV HEALTH MANAGERS LLP
SV HEALTH MANAGERS LLP is a Pre-seed, Seed, Series A, Series B and Series C+ fund in the US and Europe writing $1M–$40M checks into Enterprise, Healthcare, therapeutics, dementia, healthcare-growth and medical-devices.
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+
- Sectors
- Enterprise, Healthcare, therapeutics, dementia, healthcare-growth, medical-devices
- Check size
- $1M–$40M
- Invests in
- US-wide, Europe
- Actively investing
- Yes
- Founded
- 1993
- Assets under management
- $4B
- Website
- svhealthinvestors.com
Thesis
SV Health Managers LLP (SV Health Investors) is a healthcare and life sciences venture capital and growth equity firm with approximately $4 billion in AUM. The firm operates from offices in London and Boston, primarily focusing on North America and Europe, but remains open to opportunities in other regions. SV invests across multiple stages and sectors within healthcare, including therapeutics (biotech and dementia), healthcare growth, and medtech. Strategies include early- to late-stage biotechnology companies developing precision medicines, novel therapeutics for dementia (Dementia Discovery Fund), growth-stage healthcare services, medical products, and digital health companies (Healthcare Growth Fund), and novel medical device and remote-monitoring technologies (Medtech Convergence Fund). SV Life Sciences Fund VI has a size of $400M. The Dementia Discovery Fund (DDF-2) closed at $269 million in May 2025.
Common questions
Does SV HEALTH MANAGERS LLP invest at the Pre-seed stage?
Yes. SV HEALTH MANAGERS LLP lists Pre-seed, Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does SV HEALTH MANAGERS LLP write?
SV HEALTH MANAGERS LLP writes $1M–$40M checks.
Where does SV HEALTH MANAGERS LLP invest?
SV HEALTH MANAGERS LLP invests in the US and Europe.